Innovation and optimization in autoimmune encephalitis trials: the design and rationale for the Phase 3, randomized study of satralizumab in patients with NMDAR-IgG-antibody-positive or LGI1-IgG-antibody-positive autoimmune encephalitis (CIELO)
自身免疫性脑炎试验的创新与优化：针对 NMDAR-IgG 抗体阳性或 LGI1-IgG 抗体阳性自身免疫性脑炎患者的 satralizumab 3 期随机研究的设计和原理 (CIELO)
期刊:Frontiers in Neurology
影响因子:2.8
doi:10.3389/fneur.2024.1437913
Lee, Soon-Tae; Abboud, Hesham; Irani, Sarosh R; Nakajima, Hideto; Piquet, Amanda L; Pittock, Sean J; Yeh, E Ann; Wang, Jiawei; Rajan, Sharmila; Overell, James; Smith, Jillian; St Lambert, Jane; El-Khairi, Muna; Gafarova, Marina; Gelfand, Jeffrey M
